Uromodulin alleviates fibrosis in acute kidney injury to chronic kidney disease transition by reducing EGFR

Zheyu Xing, Kunjing Gong, Na Wang, Lufeng Bai, Nan Hu, Di Song, Yuqing Chen · 2025

Read Uromodulin alleviates fibrosis in acute kidney injury to chronic kidney disease transition by reducing EGFR by Zheyu Xing, Kunjing Gong, Na Wang, Lufeng Bai, Nan Hu, Di Song, Yuqing Chen (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12751814.txt.

Description

Zheyu Xing and co-authors study, in a 2025 paper, how a urinary protein guards the kidney as injury turns chronic. Uromodulin is made in one part of the kidney's tubes and was long guessed to protect. Rats bred without it grew up with healthy kidneys. But when lasting injury was induced, by a drug or by blocked blood flow, the missing protein made scarring far worse.

In the injured kidneys, a growth signal switch called EGFR ran too hot without uromodulin. Tests showed the protein binds that switch directly and drags it inside the cell for disposal. Adding uromodulin to human kidney cells cut both the switch's level and the scarring process. Even its small binding pieces worked the same way. The work names a concrete guard route in the kidney.

Catalog record

CREATORZheyu Xing, Kunjing Gong, Na Wang, Lufeng Bai, Nan Hu, Di Song, Yuqing Chen
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE72 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12751814

Browse the full library · About the Tower of Babel